Panel: Approaching Regulatory Affairs for iPSC-Derived Cell Therapies

Time: 2:30 pm
day: Day 2 Tracks 2 PM Clarice


  • Discussing whether regulations should vary for each iPSC product and how often regulations should be updated to influence the future of iPSC guidelines
  • Sharing experience on addressing regulations to outline preparations required
  • Addressing differences in regulations for autologous and allogeneic products to distinguish varying regulatory demands